Denali Therapeutics Inc.
PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS

Last updated:

Abstract:

The present disclosure relates to methods of making LRRK2-inhibiting, pyrimidinyl-4-aminopyrazole compounds and intermediates of formulae I and IV: The compounds are useful as LRRK2 inhibitors in the treatment of LRRK2 mediated diseases, and as intermediates for their manufacture. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

19 Dec 2018

Issue date:

14 Jan 2021